Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma

Condition:   Head and Neck Cancers
Interventions:   Drug: Durvalumab;   Drug: Docetaxel;   Drug: Cisplatin;   Drug: 5 Fluorouracil
Sponsors:   Gustave Roussy, Cancer Campus, Grand Paris;   French National Cancer Institute
Recruiting - verified May 2017

http://ift.tt/2qXSI5l